tbuckley/cabot-search huggingface dataset:
WED-182 Predicting post-TIPS hepatic encephalopathy risk in patients with cirrhosis and refractory ascites: a proof-of-concept study using a 4D MRI perfusional model
Authors: Dario Saltini, Antonio Piscopo, Luca Nocetti, Stefano Colopi, Cristian Caporali, Marcello Bianchini, Tomas Guasconi, Federico Casari, Marco Scoppettuolo, Prampolini Francesco, Andrea Salomeè Velasco Mayorga, Ascari Francesco, Antonio Colecchia, Filippo Schepis
Journal: Journal of Hepatology (2025)
SAT-318-YI Treatment coverage of the WHO 2024 hepatitis B guidelines in patients with chronic hepatitis B
Authors: Shaoqiu Zhang, Jian Wang, Chao Jiang, Ye Xiong, Tao Fan, Shengxia Yin, Jie Li, Chuanwu Zhu, Rui Huang, Chao Wu
Journal: Journal of Hepatology (2025)
OS-043-YI Clinical impact of non selective beta-blockers in patients with cirrhosis and acute kidney injury: a post hoc analysis of the international club of ascites GLOBAL-AKI study
Authors: Simone Incicco, Kavish Patidar, Ann Thu Ma, Adrià Juanola, Anna Barone, Anand Kulkarni, José Luis Pérez-Hernández, Brian Wentworth, Sumeet Asrani, Carlo Alessandria, Nadia Abdelaaty Abdelkader, Yu Jun Wong, Qing Xie, Nikolaos T. Pyrsopoulos, Sung-Eun Kim, Yasser Fouad, Aldo Torre, Eira Cerda Reyes, Javier Diaz-Ferrer, Rakhi Maiwall, Douglas Simonetto, Maria Papp, Eric Orman, Giovanni Perricone, Cristina Solé, Christian M. Lange, Alberto Farias, Gustavo Pereira, Adrian Gadano, Paolo Caraceni, Thierry Thévenot, Nipun Verma, Jeong Han Kim, Julio D. Vorobioff, Jacqueline Cordova-Gallardo, Vladimir Ivashkin, Juan Pablo Roblero, Raoel Maan, Claudio Toledo, Stefania Gioia, Eduardo Fassio, Mónica Marino, Puria Nabilou, Victor Vargas, Manuela Merli, Luciana Lofego Goncalves, Liane Rabinowich, Aleksander Krag, Lorenz Balcar, Pedro Montes, Angelo Z. Mattos, Tony Bruns, Abdulsemed Mohammed Nur, Wim Laleman, Enrique Carrera Estupiñan, Maria Cecilia Cabrera, Marcos Girala, Hrishikesh Samant, Sarah Raevens, Joao Madaleno, W. Ray Kim, Juan Pablo Arab, José Presa, Carlos Noronha Ferreira, Antonio Galante, Andrew S. Allegretti, R. Bart Takkenberg, Sebastián Marciano, Shiv Kumar Sarin, François Durand, Pere Ginès, Paolo Angeli, Elsa Solà, Salvatore Piano
Journal: Journal of Hepatology (2025)
TOP-458 qFibrosis enables earlier detection of fibrosis response in Efruxifermin-treated patients with F2-F3 MASH in 96-week HARMONY study
Authors: Jörn M. Schattenberg, Dean Tai, Elaine Chng, Yukti Choudhury, Galvin Gan, Cynthia Behling, Pierre Bedossa, Doreen Chan, Jimmie Zhang, Erica Fong, Brittany de Temple, Matthew Minerva, Mark Burch, Kimberly Barrett, Reshma Shringarpure, Erik Tillman, Tim Rolph, Andrew Cheng, Kitty Yale, Mazen Noureddin
Journal: Journal of Hepatology (2025)
OS-074 Recombinant polyclonal antibody GIGA-2339 potently neutralizes hepatitis B and hepatitis D virus
Authors: Sheila Keating, Brett Higgins, Ariel Niedecken, Yao Chiang, Peyton Witte, Raina Sharda, Yesenia Lopez, Julie Lucifora, David Durantel, Enrikas Vainorius, Carl Millward, Adam Adler
Journal: Journal of Hepatology (2025)
THU-230 Predictors of hepatocellular carcinoma risk after hepatitis C viral clearance - data from the german hepatitis C-registry (DHC-R)
Authors: Christian Niehaus, Mathias Jachs, Peter Buggisch, Hartwig Klinker, Stefan Mauss, Renate Heyne, Karl-Georg Simon, Frank Tacke, Markus Cornberg, Christoph Sarrazin, Thomas Berg, Benjamin Maasoumy
Journal: Journal of Hepatology (2025)
WED-133 A machine learning model to predict the treatment response of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma incorporating computed tomogram-derived imaging biomarkers
Authors: Moon Haeng Hur, Bo Hyun Kim, Byeong Geun Song, Dong Hyun Sinn, Youngsu Park, Yuri Cho, Jeayeon Park, Yunmi Ko, Hyunjae Shin, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Jeong-Hoon Lee
Journal: Journal of Hepatology (2025)
TOP-442-YI Somatic mutation inearlystagemetabolic-dysfunctionassociated steatotic liver disease (MASLD)
Authors: Georgeina L. Jarman, Andrew RJ Lawson, Pantelis A. Nicola, Natalia Brzozowska, Anna Paterson, Inigo Martincorena, Michael Allison, Matthew Hoare, Peter Campbell
Journal: Journal of Hepatology (2025)
FRI-414 Reproducible hepatoprotective effects and clinical translatability of long-term semaglutide treatment in the GAN diet-induced obese and biopsy-confirmed mouse model of MASH
Authors: Michael Feigh, Jacob Nøhr-Meldgaard, Sanne Skovgård Veidal, Jenny Egecioglu Norlin, Susanne Pors, Kristoffer Voldum-Clausen, Henrik B. Hansen
Journal: Journal of Hepatology (2025)
WED-119-YI Increasing prevalence of hepatocellular carcinoma in the Netherlands: changing etiologies, tumor characteristics and survival rates
Authors: Koen van Son, Kirsi van Eekhout, Judith de Vos-Geelen, E.T.T.L. Tjwa, Joep de Bruijne, Dave Sprengers, Minneke Coenraad, Frederike van Vilsteren, Joost PH Drenth, Otto van Delden, A.G. (Onno) Holleboom, Maarten Tushuizen, Lydia van der Geest, R. Bart Takkenberg
Journal: Journal of Hepatology (2025)
THU-475 Ongoing fibrosis quantification in paired liver biopsy samples from MASLD patients using AI-based digital pathology: an international multicenter study
Authors: Haiyang Yuan, Wah-Kheong Chan, Khalid A. Alswat, None Shalimar, Teruki Miyake, Jacob George, Mohamed El-Kassas, Hong You, Salvatore Petta, Waleed K. Al-Hamoudi, Yoichi Hiasa, Keshni Sharma, Sandeep Aggarwal, Mohammed Emadeldeen, Xiao-Fei Tong, Grazia Pennisi, Yayun Ren, Xin-Lei Wang, Dean Tai, Ming-Hua Zheng
Journal: Journal of Hepatology (2025)
GS-012 Efruxifermin improves fibrosis in participants with compensated cirrhosis due to MASH: results of a 96-week, randomized, doubleblind, placebo-controlled, phase 2b trial (SYMMETRY)
Authors: Mazen Noureddin, Mary E. Rinella, Naga Chalasani, Guy Neff, Kathryn Lucas, Manuel Rodriguez, Madhavi Rudraraju, Rashmee Patil, Cynthia Behling, Mark Burch, Doreen Chan, Erik Tillman, Arian Zari, Brittany de Temple, Reshma Shringarpure, Meena Jain, Tim Rolph, Andrew Cheng, Kitty Yale
Journal: Journal of Hepatology (2025)
SAT-512 HepatoPredict has a good prognostic value in patients with hepatocellular carcinoma independently of biopsied nodule
Authors: Rita Andrade, Silvia Gomes Silva, Migla Miskinyte, Margarida Quaresma, Laura Frazão, Carolina Peixoto, Antonio Figueiredo, Maria Agusta Cipriano, Maria Reis, Daniela Proença, André Folgado, Jose Pereira-Leal, Rui Oliveira, Hugo Pinto Marques, José Guilherme Tralhão, Joana Cardoso
Journal: Journal of Hepatology (2025)
THU-136 Clinical relevance of the evaluation of cardiorespiratory fitness in patients with cirrhosis: a systematic review with meta-analysis
Authors: Alexis Couret, Fabrice Rannou, Bruno Pereira, Martine Duclos, James King, Sébastien Dharancy, Rémi Nevieère, Delphine Weil-Verhoeven, Gael Ennequin, Armand Abergel
Journal: Journal of Hepatology (2025)
FRI-091-YI The “A-B-C” cluster-based classification reveals distinct outcome trajectories in patients with hepatocellular carcinoma under atezolizumab/bevacizumab
Authors: Claudia Campani, Clelia Galvanin, Ju Hyun Shim, Mohamed Bouattour, Yann Touchefeu, Victoria Delhoume, Olivier Rosmorduc, Alina Pascale, Jihyun An, Han Chu Lee, Héleène Regnault, Dominique Thabut, Giuliana Amaddeo, Manon Allaire, Isabelle Ollivier-Hourmand, Chloe Metivier, Elena Rondini, Maxime Ronot, Line Carolle Ntandja Wandji, Violaine Ozenne, Sabrina Sidali, Fabio Marra, Clemence Hollande, Nathalie Ganne-Carrié, Pierre Nahon, Marie Lequoy, Rohini Sharma, Massih Ningarhari, Eric Trépo, Jean Charles Nault
Journal: Journal of Hepatology (2025)
SAT-046 Effects of N-acylethanolamines in an in vitro model of metabolic stress: evidence on autophagy and related pathways in hepatic cells
Authors: Nicole Pia Navatti, Stefania Melini, Filomena Del Piano, Federica Comella, Nicola Opallo, Chiara Annunziata, Giuseppina Mattace Raso, Federico Pietrocola, Claudio Pirozzi, Rosaria Meli
Journal: Journal of Hepatology (2025)
WED-232 Assessing portal hypertension with endoscopic ultrasound portal pressure gradient (eus-ppg): clinical correlations and procedural outcomes
Authors: Francesco Martini, Lucia Salvi, Giulia Scandali, Chiara Scorzoni, Daniele Balducci, Marco Marzioni, Luca Maroni, Antonio Benedetti, Giuseppe Tarantino
Journal: Journal of Hepatology (2025)
WED-196-YI Validation of the blood-based Vienna 3P/5P portal hypertension risk models in patients with compensated advanced chronic liver disease
Authors: Georg Kramer, Benedikt Simbrunner, Mathias Jachs, Lorenz Balcar, Benedikt Hofer, Nina Dominik, Lukas Hartl, Michael Schwarz, Christian Sebesta, Georg Semmler, Paul Thöne, Oleksandr Petrenko, Jiří Reiniš, Philipp Schwabl, Albert Friedrich Stättermayer, Michael Trauner, Mattias Mandorfer, Thomas Reiberger
Journal: Journal of Hepatology (2025)
WED-200 Non-invasive prediction of clinically significant portal hypertension in patients with compensated advanced chronic liver disease of different aetiologies
Authors: Giulia Francesca Manfredi, Davide Di Benedetto, Carla de Benedittis, Michela Burlone, Mattia Lotto, Angelo Strada, Rosalba Minisini, Mario Pirisi, Cristina Rigamonti
Journal: Journal of Hepatology (2025)
SAT-160 Phase angle as a predictive factor for mortality in hospitalized patients with cirrhosis
Authors: Fajardo Ordóñez Javier, Jordi Sánchez, Eva Roman, Mireia Miquel, Naujot Kaur, José Ferrusquía-Acosta, Maria Poca, Cristina Solé, Berta Cuyàs, Meritxell Casas, Edilmar Alvarado-Tapias, Teresa Monllor-Nunell, Alforcea Sheila, Ferrero Andreu, Anna Brujats, Mercedes Vergara, Àngels Escorsell, German Soriano
Journal: Journal of Hepatology (2025)
OS-070 Achieving undetectable hepatitis delta virus RNA at end of therapy with bulevirtide 10 mg/day with or without with pegylated interferon alpha is strongly associated with post-treatment virologic response in chronic hepatitis delta
Authors: Fabien Zoulim, Tarik Asselah, Soo Aleman, Maurizia Brunetto, Vladimir Chulanov, Adrian Streinu-Cercel, George Sebastian Gherlan, Pavel Bogomolov, Tatiana Stepanova, Viacheslav Morozov, Olga Sagalova, Renee-Claude Mercier, Lei Ye, Amos Lichtman, Dmitry Manuilov, Heiner Wedemeyer, Pietro Lampertico
Journal: Journal of Hepatology (2025)
FRI-275 Characterization of antigen specificity of T cell responses and HBV neutralization activity in a cohort of patients who achieved HBV HBsAg loss
Authors: Tai-Chung Tseng, Chunfeng Li, Savrina Manhas, Simin Xu, Ping Yi, Pamela Odorizzi, Nithya Swaminathan, Andrew Lopez, Nadine Peinovich, Clarissa Martinez, Thomas Aeschbacher, Jenny Lumb, Caleb Marceau, Ross Martin, Scott Balsitis, Simon Fletcher, Tomas Cihlar, Hongmei Mo, Jenny Svarovskaia, Kmurata Murata, Young-Suk Lim
Journal: Journal of Hepatology (2025)
SAT-501 Steatosis predicts poor abstinence rates in patients with alcohol use disorder
Authors: Queralt Herms, Jordi Gratacós-Gineès, Emma Avitabile, Marina Vélez, Ana Belén Rubio, Martina Perez-Guasch, Marta Cervera, Ruth Nadal, Maria Teresa Pons, Pol Bruguera, Anna Lligoña, Ana Lopez Lazcano, Lluisa Ortega, Marta Carol, Anita Arslanow, Núria Fabrellas, María José Moreta, Anna Soria, Adrià Juanola, Isabel Graupera, Ramon Bataller, Pere Gineès, Hugo Lopez, Elisa Pose
Journal: Journal of Hepatology (2025)
SAT-157 Identification of sarcopenia in patients with liver cirrhosis by combining anthropometry and ultrasound of thigh and psoas
Authors: Isabel Campos-Varela, Carlos Céspedes, Ester Palacio, Sergi Quiroga, Nuria Roson, Elena Vargas-Accarino, Macarena Simón-Talero, Victor Vargas Blasco, Lluis Castells
Journal: Journal of Hepatology (2025)
SAT-166 Use of light-EEG to rule out covert hepatic encephalopathy in advanced chronic liver disease
Authors: Juliana Goediker, Isabel Korte, Johannes Chang, Abu-Omar Jasmin, Luisa Klotz, Sara Noemi Reinartz Groba, Markus Kimmann, Silvia Letmathe, Jörn Arne Meier, Jonel Trebicka, Michael Praktiknjo
Journal: Journal of Hepatology (2025)
FRI-495-YI Hypothermic oxygenated machine perfusion (HOPE) treatment prior to organ transplant alters key immune modulators in patients receiving liver transplantation
Authors: Maike Rebecca Pollmanns, Johanna Reißing, Josua Johnsen, Johan Hohenschwert, Dominik Krautgartner, Felix Oldhafer, Ulf Peter Neumann, Florian Vondran, Alexander Koch, Tony Bruns, Theresa Hildegard Wirtz
Journal: Journal of Hepatology (2025)
LBP-024 Metabolic dysfunction- and alcohol-associated steatotic liver disease is associated with higher risk of advanced fibrosis and mortality than metabolic dysfunction-associated steatotic liver disease: data from a large global biopsy-proven cohort
Authors: Zobair Younossi, Leyla de Avila, Salvatore Petta, Atsushi Nakajima, Javier Crespo, Seung Up Kim, Laurent Castera, Ming-Hua Zheng, Emmanuel Tsochatzis, Shenoy Kotacherry Trivikrama, Shalimar Shalimar, Khalid A Alswat, Yusuf Yilmaz, Ming-Lung Yu, Sven Francque, Wah-Kheong Chan, Marlen Ivon Castellanos Fernández, Sombat Treeprasertsuk, Ajay Kumar Duseja, Adrian Gadano, Claudia P. Oliveira, Juan Pablo Arab, George Papatheodoridis, Luis Antonio Diaz, Giada Sebastiani, Roberta D’Ambrosio, Arun Valsan, Al Naamani Khalid, A.G. (Onno) Holleboom, Mohamed El-Kassas, Nicola Pugliese, Ashwani K. Singal, Brian Pearlman, Narendra S. Choudhary, Ahmed Cordie, Nadege Gunn, Cyrielle Caussy, Didac Mauricio, Takumi Kawaguchi, Francesco Paolo Russo, Arathi Venu, Hannes Hagström, Naim Alkhouri, Prooksa Ananchuensook, Leena Mohan, Jiangao Fan, Stuart Roberts, Vincent Wai-Sun Wong, Winston Dunn, Mattias Ekstedt, George Boon Bee Goh, Mário Pessoa, Pietro Lampertico, Grazia Pennisi, Ying Shang, Wen-Yue Liu, Hye Won Lee, Takashi Kobayashi, Satoru Kakizaki, Paula Iruzubieta, Rida Nadeem, Felice Cinque, Antonia Neonaki, Mirko Zoncapè, Rui-Xu Yang, Sherlot Juan Song, Nicholas Dunn, Zouhir Gadi, Ming-Lun Yeh, Kevin Kim Jun Teh, Sanjiv Mahadeva, Licet Gonzalez Fabian, Ahmed Almohsen, Nathalie LeiteJohan Vessby, Chencheng Xie, Ethan Friend, Maria Poca, Bérénice Ségrestin, Marco Arrese, Brian Lam, Andrei Racila, Saleh Alqahtani, Maria Stepanova Johan Vessby, Chencheng Xie, Ethan Friend, Maria Poca, Bérénice Ségrestin, Marco Arrese, Brian Lam, Andrei Racila, Saleh Alqahtani, Maria Stepanova
Journal: Journal of Hepatology (2025)
THU-260 IM-PROVE I: characterization of chronic hepatitis B (CHB) subjects with functional cure or HBV DNA suppression after completion of imdusiran plus short courses of pegylated interferon alfa-2a (IFN) and discontinuation of nucleos(t)ide analogue (NA) therapy
Authors: Man-Fung Yuen, Ronald G. Nahass, Grace Lai-Hung Wong, Tatiana Burda, Tuan T. Nguyen, Young-Suk Lim, Wan-Long Chuang, Eugene R. Schiff, Kalyan Bhamidimarri, Kevin Gray, Emily P. Thi, Christine L. Espiritu, Elina Medvedeva, Timothy Eley, Mark Anderson, Tiffany Fortney, Gavin Cloherty, Karen D. Sims
Journal: Journal of Hepatology (2025)
OS-097 Evaluating noninvasive diagnostic pathways for identifying MASH patients eligible for Resmetirom therapy: a real-world cohort analysis
Authors: Winston Dunn, Ashwani K. Singal, Imad Asaad, Edward Mena, Amreen Dinani, Savannah Nelson, Wamda Ahmed, Karthikeya Kodali, Phuong Nguyen, Sonal Kumar, Madhavi Rudraraju, Mazen Noureddin, Naim Alkhouri
Journal: Journal of Hepatology (2025)
THU-352 The histological activity index is associated with disease severity and treatment response in patients with immune mediated liver injury from checkpoint inhibitors
Authors: Robert Fontana, Lucy Meunier, David E Kleiner, Benjamin Riviere, Dominique Larrey, Vincent Chen, Jiezhun Gu, Huiman Barnhart, Alisa Likhitsup, Lina Hountondji
Journal: Journal of Hepatology (2025)
THU-176 Sex-specific differences in preclinical models of advanced chronic liver disease and portal hypertension
Authors: Peio Aristu, Maria Andres-Rozas, Zoe Boyer-Diaz, David Al-Adra, Douglas Maya-Miles, Sergi Guixe-Muntet, Anabel Fernández-Iglesias, Jordi Gracia-Sancho
Journal: Journal of Hepatology (2025)
OS-101-YI Concomitant diabetes mellitus in untreated chronic hepatitis B with low-level viremia is associated with increased risk of hepatocellular carcinoma: validating the world health organization 2024 recommendations
Authors: RexWan-Hin Hui, Xianhua Mao, Matthew Shing Hin Chung, Lu Li, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip, Lung Yi Loey Mak, Man-Fung Yuen, Wai-Kay Seto
Journal: Journal of Hepatology (2025)
LBP-002 High-throughput combinatorial CRISPR screening in hepatic progenitor cell-derived organoids reveals genetic determinants of response to standard-of-care chemotherapy in cholangiocarcinoma
Authors: Michael Girma Mamo, Michael Adisasmita, Hyomin Lee, Myounghoi Kim, Elsy Soraya Salas Silva, Woochang Hwang, Ji Hyun Shin, Junho Hur, Dongho Choi
Journal: Journal of Hepatology (2025)
THU-229-YI Increasing risk of hepatic decompensation in patients with HCV related liver cirrhosis during long-term follow up after sustained virological response (SVR) - data from the german hepatitis C- registry (DHC-R)
Authors: Christian Niehaus, Mathias Jachs, Peter Buggisch, Hartwig Klinker, Stefan Mauss, Renate Heyne, Karl-Georg Simon, Frank Tacke, Stefan Zeuzem, Thomas Berg, Heiner Wedemeyer, Benjamin Maasoumy
Journal: Journal of Hepatology (2025)
SAT-503-YI Cardiac performance is impaired in patients with proven alcohol related hepatitis and and predicts 3-month mortality in this patient population
Authors: Hortense Le Bourhis, Shantha Valainathan, Alexandre Sayadi, Audrey Payancé, Olivier Roux, Lucile Moga, Claire Francoz, Francois Durand, Valérie Paradis, Pierre-Emmanuel Rautou
Journal: Journal of Hepatology (2025)
THU-487 Liver-targeted mRNA therapeutics through fibroblast growth factor 21 and apolipoprotein A1 delivery in experimental acute pancreatitis
Authors: Amaya Lopez-Pascual, Eva Santamaria, Nuria Ardaiz, Iker Uriarte, Tiffany Palmer, Anne-Renee Graham, Celia Gomar, Roberto Barbero, Maria U Latasa, Maria Arechederra, Jesus M Urman, Carmen Berasain, Antonio Fontanellas, Carlos del Rio, Maite G Fernandez-Barrena, Paolo Martini, Joshua R Schultz, Pedro Berraondo, Matías A Avila
Journal: Journal of Hepatology (2025)
TOP-251 Efficacy and safety of Bemnifosbuvir and Ruzasvir after 8 weeks of treatment in patients with chronic hepatitis C virus (HCV) infection
Authors: Alina Jucov, Saeed Sadiq Hamid, Laura Iliescu, Elena Ermacicova, Shannan Lynch, Marina Majarian, Sergey Izmailyan, Qi Huang, Xiao-Jian Zhou, Keith Pietropaolo, Bruce Belanger, Maria Arantxa Horga, Janet Hammond
Journal: Journal of Hepatology (2025)
WED-272 Real-world efficacy and safety of universal 8-week Glecaprevir/ Pibrentasvir in CHC patients with early CKD or Pre-ESRD: insights from a nationwide HCV registry in Taiwan
Authors: Sih-Ren Wang, Chung-Feng Huang, Te-Sheng Chang, Chingchu Lo, Chao-Hung Hung, Chien-Wei Huang, Lee-Won Chong, Pin-Nan Cheng, Ming-Lun Yeh, Cheng-Yuan Peng, Chien-Yu Cheng, Jee-Fu Huang, Ming-Jong Bair, Chih-Lang Lin, Chi-Chieh Yang, Hsing-Tao Kuo, Tsai-Yuan Hsieh, Tzong-Hsi Lee, Pei-Lun Lee, Wen-Chih Wu, Chih-Lin Lin, Wei-Wen Su, Sheng-Shun Yang, Chia-Chi Wang, Jui-Ting Hu, Lien-Ray Mo, Chun-Ting Chen, Yi-Hsiang Huang, Chun-Chao Chang, Chia-Sheng Huang, Guei-Ying Chen, Chien-Neng Kao, Chi-Ming Tai, Chun-Jen Liu, Mei-Hsuan Lee, Pei-Chien Tsai, Chia-Yen Dai, Jia-Horng Kao, Han-Chieh Lin, Wan-Long Chuang, Kuo-Chih Tseng, Chi-Yi Chen, Ming-Lung Yu
Journal: Journal of Hepatology (2025)
LBO-002 Treatment with resmetirom for up to two years led to improvement in liver stiffness, fibrosis biomarkers, fibrosis scores and portal hypertension risk in 122 patients with compensated MASH cirrhosis
Authors: Naim Alkhouri, Rebecca Taub, Xiaomin Lu, Richard Pushkin, Michael R. Charlton, Sam Moussa, Anita Kohli, Mazen Noureddin, Jörn M. Schattenberg
Journal: Journal of Hepatology (2025)
THU-269 Interim results of a phase I/II study to determine the safety, immunogenicity and efficacy of therapeutic hepatitis B virus synthetic long peptide vaccination
Authors: Roel Pieterman, Anna-Sophia Wiekmeijer, May Young Lin, Robbie Luijten, Patrick Boor, Judith Verhagen-Oldenampsen, Elke Verhey, Hanneke van Soest, Cornelis Melief, Patrick van der Veek, Pieter Honkoop, R. Bart Takkenberg, Rachida Bouamar, Milan J. Sonneveld, Harry L.A. Janssen, Dave Sprengers, Sonja Buschow
Journal: Journal of Hepatology (2025)
THU-215 Characterising prevalence and unmet needs in the setting of funded hepatitis C therapy - automated hepatitis screening in australian emergency departments can assist
Authors: Julia Di Girolamo, Alexander Prudence, Melissa Bagatella, Sicha Manandhar, Joseph Pipicella, Krishan Pratap, Irena Petrovski, Sokaina Ahmadi, Alice Lee, Ian Turner, Jeremy Lawrence, Richard Cracknell, Laura Hutchinson, Matthew Smith, Alex Mackey, Michael Maley, Hong Foo, Nathan Jones, Gregory Dore, David Prince, Miriam Levy
Journal: Journal of Hepatology (2025)
WED-276 The SVR10K Hepatitis C study: final results show 98.9% SVR in 7,000 patients treated with SOF/VEL in Asia, Latin America, Middle East, Nordic and Southern Europe
Authors: Soo Aleman, Ming-Lung Yu, Fatima Higuera-de-la-Tijera, Francisco Javier Garcia-Samaniego, Marta Casado-Martin, Grace Lai-Hung Wong, Mario Álvares-da-Silva, Joaquin Cabezas, Miguel Castruita, Oscar Beltran, Mohammed Alzaabi, Aastha Chandak, Marta Martinez, Artak Khachatryan, Linda Chen, Candido Hernández, Kim Vanstraelen, Yu Jun Wong
Journal: Journal of Hepatology (2025)
THU-223-YI Implementation of a systematic hepatitis C screening program: insights from a regional approach and its impact on diagnosis and treatment outcomes
Authors: Madalena Pestana, Vítor Magno Pereira, Elisa Xavier, Nancy Faria, Ana Reis, Nuno Ladeira, Paulo Câmara, Alba Carrodeguas, José Luis Gonzalez, Nuno Canhoto, José Bruno Freitas, Henrique Morna
Journal: Journal of Hepatology (2025)
WED-316-YI Treatment response to bulevirtide leads to improvement of portal hypertension in patients with chronic hepatitis D virus infection: results from the prospective IMPHROVE-D study
Authors: Lisa Sandmann, Mathias Jachs, Tammo Lambert Tergast, Lukas Hartl, Birgit Bremer, Martin Kabelitz, Michael Schwarz, Paul Thöne, Julius Egge, Lorenz Balcar, Benedikt Hofer, Christine Falk, Albert Friedrich Stättermayer, Markus Cornberg, Michael Trauner, Katja Deterding, Mattias Mandorfer, Heiner Wedemeyer, Thomas Reiberger, Benjamin Maasoumy
Journal: Journal of Hepatology (2025)
THU-213 HCC risk stratification scores: insights from large multi-center national cohort study
Authors: Imam Waked, Wafaa El-Akel, Mohamed AbdAllah, Magdi El-Serafy, Mohamed Hassany, Aisha Elsharkawy, Riham Soliman, Gamal Shiha, Gamal Esmat, Wahed Doss
Journal: Journal of Hepatology (2025)
WED-314 Hepatocellular carcinoma risk in patients with chronic hepatitis B: Tenofovir Disoproxil Fumarate vs Tenofovir Alafenamide from a korean nationwide study
Authors: Ji won Yang, Jihye Lim, Jina Park, Ye-Jee Kim, Hwa Jung Kim, Jonggi Choi
Journal: Journal of Hepatology (2025)
TOP-267 Refining HCC risk prediction in non-ACLD chronic hepatitis patients after antiviral therapy: insights from a multicenter study
Authors: Yen-Chun Liu, Te-Sheng Chang, Chi-Yi Chen, Ya-Ting Cheng, Yi-Cheng Chen, Yi-Chung Hsieh, Rachel Wen-Juei Jeng, Chun-yen Lin, Rong-Nan Chien, Tai Dar-In, I-Shyan Sheen
Journal: Journal of Hepatology (2025)
TOP-252 HBsAg decline and clearance with peg-IFN add-on therapy – an individual participant data meta-analysis of prospective trials (PROSPER)
Authors: Edo J. Dongelmans, Lesley Patmore, Seng Gee Lim, Marc Bourliere, Shao-wen Jiang, Nathalie Ganne-Carrié, Willem Pieter Brouwer, Jordan J. Feld, Jose A. Carrión, Teresa Broquetas, Scott K. Fung, Fabrice Carrat, Fabien Zoulim, Bettina E. Hansen, Qing Xie, Harry L.A. Janssen, Milan J. Sonneveld
Journal: Journal of Hepatology (2025)
SAT-305 Qualitative interviews to explore multicultural appropriateness and content validity of the hepatitis B quality of life (HBQOL) among highly impacted populations (chinese and vietnamese) with chronic hepatitis B (CHB) in the US
Authors: Naveen Gara, Marvin Rock, Caroline Burk, Larissa Stassek, Sonya Stanczyk, Alireza Farabi, Cainan Foltz, Tuan T. Nguyen
Journal: Journal of Hepatology (2025)